# Eli Lilly and Company (LLY) — Q3-2013 Earnings Results

**Report date:** 2013-10-23 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/LLY/earnings/Q3-2013

## Post-Earnings Brief

### Headline

Eli Lilly Beats on EPS, Stock Up 0.32%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.11 | N/A | +6.02% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed satisfaction with the EPS results, indicating a focus on future product developments. They emphasized their commitment to innovation in the healthcare space.

**Key quotes:**

> We are pleased with our EPS performance this quarter.

> Our focus remains on delivering innovative treatments.

### Guidance Changes

No guidance updates were provided during the earnings call.

### What It Means

Eli Lilly's earnings report showed a positive surprise in EPS, which contributed to a slight increase in stock price. Investors reacted favorably to the earnings beat, despite the lack of revenue data and guidance. The company's focus on innovation suggests potential for future growth, but the absence of specific guidance leaves some uncertainty.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/LLY/earnings/Q3-2013_